ARCA biopharma, Inc. (ABIO) Social Stream

Featured Post From StockTwits About ABIO

Will post Telegram to join my team once posts complete, follow and don’t miss out! Have a blessed weekend!

$ABIO
Market Price - $2.90
Average Hold - $3.50
Accumulate - Sub $2.75
Price Target - $5
Estimated Time Hold - (2-3Q)
Support - $3.25, $7.50
Floor - $2.63
Double Down Target - Sub $2.75
Option - N/A
Micro DD - rNAPc2, a small recombinant protein being developed as a potential treatment for RNA virus associated disease, initially focusing on COVID-19. Gencaro, a pharmacologically unique beta-blocker and mild vasodilator being developed as a potential genetically-targeted treatment for atrial fibrillation (AF) in patients with heart failure. Cash and cash equivalents were $63.2M as of June 30, 2021, compared to $49.1M as of December 31, 2020. ARCA believes that its current cash and cash equivalents will be sufficient to fund its operations through 2022.